B. Braun addEASE Binary Connector: Class I Recall -Stopper Fragments May Enter Bag

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: B. Braun addEASE Binary Connector: Class I Recall -Stopper Fragments May Enter Bag
MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

B. Braun addEASE Binary Connector: Class I Recall -Stopper Fragments May Enter Bag

AUDIENCE: Risk Manager

ISSUE: When the addEASE binary connector is inserted into a partial additive bag (PAB) stopper, fragments of the stopper may enter the bag, resulting in a small amount of visible particles in the solution.   The particles can potentially enter a patient’s body and lead to serious adverse health consequences, such as pulmonary embolism, stroke, or heart attack.  These issues could result in serious injury or death.

BACKGROUND: The addEASE is used to transfer fluid between a partial additive bag (PAB) and a drug vial.

RECOMMENDATION: On June 28, 2010 B Braun sent an Urgent Medical Device Recall letter to its customers informing them of the recall and advising them to immediately stop using or distributing addEASE connectors. 

Braun PAB containers can continue to be used safely with a standard syringe and needle in accordance with the Directions for Use.  

Healthcare professionals are encouraged to report adverse events related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Read the complete MedWatch Safety Alert at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm235283.htm

 


Tell us what you think:

http://survey.foreseeresults.com/survey/display?cid=d509U9xg0gZVxkMRcoMsQg==&sid=link&cpp[date]=11_30_2010-1730&cpp[type]=S

 

You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm

Follow MedWatch on Twitter twitter

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

FDA HHS

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux